Manual on the proper use of lutetium-177-labeled somatostatin analogue (Lu-177-DOTA-TATE) injectable in radionuclide therapy (2nd ed.)

Here we present the guideline for the treatment of neuroendocrine tumors using Lu-177-DOTA-TATE on the basis of radiation safety aspects in Japan. This guideline was prepared by a study supported by Ministry of Health, Labour, and Welfare, and approved by Japanese Society of Nuclear Medicine. Lu-177...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosono, Makoto, Ikebuchi, Hideharu, Nakamura, Yoshihide, Nakamura, Nobutaka, Yamada, Takahiro, Yanagida, Sachiko, Kitaoka, Asami, Kojima, Kiyotaka, Sugano, Hiroyasu, Kinuya, Seigo, Inoue, Tomio, Hatazawa, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2018
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852188/
https://www.ncbi.nlm.nih.gov/pubmed/29333565
http://dx.doi.org/10.1007/s12149-018-1230-7
_version_ 1783306519344840704
author Hosono, Makoto
Ikebuchi, Hideharu
Nakamura, Yoshihide
Nakamura, Nobutaka
Yamada, Takahiro
Yanagida, Sachiko
Kitaoka, Asami
Kojima, Kiyotaka
Sugano, Hiroyasu
Kinuya, Seigo
Inoue, Tomio
Hatazawa, Jun
author_facet Hosono, Makoto
Ikebuchi, Hideharu
Nakamura, Yoshihide
Nakamura, Nobutaka
Yamada, Takahiro
Yanagida, Sachiko
Kitaoka, Asami
Kojima, Kiyotaka
Sugano, Hiroyasu
Kinuya, Seigo
Inoue, Tomio
Hatazawa, Jun
author_sort Hosono, Makoto
collection PubMed
description Here we present the guideline for the treatment of neuroendocrine tumors using Lu-177-DOTA-TATE on the basis of radiation safety aspects in Japan. This guideline was prepared by a study supported by Ministry of Health, Labour, and Welfare, and approved by Japanese Society of Nuclear Medicine. Lu-177-DOTA-TATE treatment in Japan should be carried out according to this guideline. Although this guideline is applied in Japan, the issues for radiation protection shown in this guideline are considered internationally useful as well. Only the original Japanese version is the formal document.
format Online
Article
Text
id pubmed-5852188
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Japan
record_format MEDLINE/PubMed
spelling pubmed-58521882018-03-21 Manual on the proper use of lutetium-177-labeled somatostatin analogue (Lu-177-DOTA-TATE) injectable in radionuclide therapy (2nd ed.) Hosono, Makoto Ikebuchi, Hideharu Nakamura, Yoshihide Nakamura, Nobutaka Yamada, Takahiro Yanagida, Sachiko Kitaoka, Asami Kojima, Kiyotaka Sugano, Hiroyasu Kinuya, Seigo Inoue, Tomio Hatazawa, Jun Ann Nucl Med Report Here we present the guideline for the treatment of neuroendocrine tumors using Lu-177-DOTA-TATE on the basis of radiation safety aspects in Japan. This guideline was prepared by a study supported by Ministry of Health, Labour, and Welfare, and approved by Japanese Society of Nuclear Medicine. Lu-177-DOTA-TATE treatment in Japan should be carried out according to this guideline. Although this guideline is applied in Japan, the issues for radiation protection shown in this guideline are considered internationally useful as well. Only the original Japanese version is the formal document. Springer Japan 2018-01-15 2018 /pmc/articles/PMC5852188/ /pubmed/29333565 http://dx.doi.org/10.1007/s12149-018-1230-7 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Report
Hosono, Makoto
Ikebuchi, Hideharu
Nakamura, Yoshihide
Nakamura, Nobutaka
Yamada, Takahiro
Yanagida, Sachiko
Kitaoka, Asami
Kojima, Kiyotaka
Sugano, Hiroyasu
Kinuya, Seigo
Inoue, Tomio
Hatazawa, Jun
Manual on the proper use of lutetium-177-labeled somatostatin analogue (Lu-177-DOTA-TATE) injectable in radionuclide therapy (2nd ed.)
title Manual on the proper use of lutetium-177-labeled somatostatin analogue (Lu-177-DOTA-TATE) injectable in radionuclide therapy (2nd ed.)
title_full Manual on the proper use of lutetium-177-labeled somatostatin analogue (Lu-177-DOTA-TATE) injectable in radionuclide therapy (2nd ed.)
title_fullStr Manual on the proper use of lutetium-177-labeled somatostatin analogue (Lu-177-DOTA-TATE) injectable in radionuclide therapy (2nd ed.)
title_full_unstemmed Manual on the proper use of lutetium-177-labeled somatostatin analogue (Lu-177-DOTA-TATE) injectable in radionuclide therapy (2nd ed.)
title_short Manual on the proper use of lutetium-177-labeled somatostatin analogue (Lu-177-DOTA-TATE) injectable in radionuclide therapy (2nd ed.)
title_sort manual on the proper use of lutetium-177-labeled somatostatin analogue (lu-177-dota-tate) injectable in radionuclide therapy (2nd ed.)
topic Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852188/
https://www.ncbi.nlm.nih.gov/pubmed/29333565
http://dx.doi.org/10.1007/s12149-018-1230-7
work_keys_str_mv AT hosonomakoto manualontheproperuseoflutetium177labeledsomatostatinanaloguelu177dotatateinjectableinradionuclidetherapy2nded
AT ikebuchihideharu manualontheproperuseoflutetium177labeledsomatostatinanaloguelu177dotatateinjectableinradionuclidetherapy2nded
AT nakamurayoshihide manualontheproperuseoflutetium177labeledsomatostatinanaloguelu177dotatateinjectableinradionuclidetherapy2nded
AT nakamuranobutaka manualontheproperuseoflutetium177labeledsomatostatinanaloguelu177dotatateinjectableinradionuclidetherapy2nded
AT yamadatakahiro manualontheproperuseoflutetium177labeledsomatostatinanaloguelu177dotatateinjectableinradionuclidetherapy2nded
AT yanagidasachiko manualontheproperuseoflutetium177labeledsomatostatinanaloguelu177dotatateinjectableinradionuclidetherapy2nded
AT kitaokaasami manualontheproperuseoflutetium177labeledsomatostatinanaloguelu177dotatateinjectableinradionuclidetherapy2nded
AT kojimakiyotaka manualontheproperuseoflutetium177labeledsomatostatinanaloguelu177dotatateinjectableinradionuclidetherapy2nded
AT suganohiroyasu manualontheproperuseoflutetium177labeledsomatostatinanaloguelu177dotatateinjectableinradionuclidetherapy2nded
AT kinuyaseigo manualontheproperuseoflutetium177labeledsomatostatinanaloguelu177dotatateinjectableinradionuclidetherapy2nded
AT inouetomio manualontheproperuseoflutetium177labeledsomatostatinanaloguelu177dotatateinjectableinradionuclidetherapy2nded
AT hatazawajun manualontheproperuseoflutetium177labeledsomatostatinanaloguelu177dotatateinjectableinradionuclidetherapy2nded

Ejemplares similares